Yes, RNA-based therapies hold significant promise in cancer treatment. These therapies include antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), and miRNA mimics or inhibitors. ASOs and siRNAs can target specific mRNA sequences to inhibit the expression of oncogenes or restore the function of tumor suppressor genes. miRNA-based therapies aim to normalize the levels of dysregulated miRNAs in cancer cells. Although still in the experimental stage, some RNA-based therapies have shown promising results in preclinical and clinical studies.
